12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SYN120: Phase I started

Biotie began a U.S. Phase I trial to evaluate SYN120 in up to 20 healthy volunteers. Biotie gained rights to SYN120 through its February acquisition of ...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >